0001144204-14-060147.txt : 20141008 0001144204-14-060147.hdr.sgml : 20141008 20141008160527 ACCESSION NUMBER: 0001144204-14-060147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141007 FILED AS OF DATE: 20141008 DATE AS OF CHANGE: 20141008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tulip Thomas H. CENTRAL INDEX KEY: 0001528192 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 141147941 MAIL ADDRESS: STREET 1: 425 METRO PLACE N., SUITE 300 CITY: DUBLIN STATE: OH ZIP: 43017 4 1 form470708_20141008040416-.xml X0306 4 2014-10-07 0 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001528192 Tulip Thomas H. 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH US 43017 0 1 0 0 President Common Stock 2014-10-06 4 A 0 20000 0 A 65000 D Common Stock 2014-10-06 4 F 0 6582 1.34 D 58418 D Common Stock 4473 I By 401(k) Shares acquired pursuant to vesting of performance-based restricted stock upon achieving performance criteria. Shares withheld by the Issuer to satisfy tax withholding obligations upon the vesting of the restricted stock. William J. Kelly, Attorney-in-Fact 2014-10-08